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Graphical abstract 
 
Highlights 
 Immunocastration decreased concentration of testosterone in ram lambs 
 Vaccination intervals of two, three and four weeks decreased androgen production  
 Immunocastration decreased testes weight and seminiferous tubule size 
 Shorter vaccination intervals decreased seminiferous tubule epithelium thickness the 
most 
 
Abstract 
The objective of this study was to establish whether different intervals between primary and 
secondary immunocastration vaccinations had similar effects on the production of C-19 steroid 
hormones and testis tissue functionality. Forty Dohne Merino rams (5.5 months old) were 
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allocated to the respective treatment groups, which included no vaccination (R), and four (IC4), 
three (IC3) or two (IC2) weeks between the primary and secondary vaccination.  
Administration of the secondary vaccination to all immunocastrated lambs occurred four weeks 
prior to slaughter. Blood samples were collected weekly for eight weeks, and serum C-19 
steroid metabolites were determined with ultra-performance convergence chromatography 
tandem mass spectrometry. Testes were collected at slaughter to assess size and level of tissue 
activity, as indicated by the cut surface CIE Lab colour measurement, seminiferous tubule 
circumference and seminiferous tubule epithelium thickness. Serum cortisol concentrations 
fluctuated but immunocastration had no influence. Serum testosterone concentrations 
decreased in IC4, IC3 and IC2 lambs between primary and secondary vaccinations, but 
consistently low testosterone concentrations (< 0.5 ng/mL) were only observed a week after 
the secondary vaccination. Immunocastration resulted in a decrease in testis weight, 
seminiferous tubule circumference and tubule epithelium thickness across all vaccination 
treatments, which indicates impaired spermatogenesis. However, the most pronounced 
decrease in seminiferous tubule epithelium depth was observed in the testes of IC3 and IC2 
lambs. The CIE colour a* values measured on the cut testis surface differed between 
vaccination intervals, indicating potential differences in the extent of interrupted activity. 
Therefore, the immunocastration vaccination interval of lambs is flexible, while still being 
successful in suppressing testosterone secretion and interrupting functioning of the testes. 
 
 
Abbreviations: R, intact ram; IC2/3/4, lamb immunocastrated with a two/three/four-week 
interval between doses; LH, Luteinizing hormone; GnRH, gonadotropin-releasing hormone; 
DHEA, dehydroepiandrosterone; A4, androstenedione; T, testosterone; FSH, follicle-
stimulating hormone; 11OHA4, 11β-hydroxyandrostenedione; DHT, 5α-dihydrotestosterone; 
D, day; UPC2-MS/MS, ultra-performance convergence chromatography tandem mass 
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spectrometry; MTBE, tert-methyl butyl ether; CORT, cortisol; PROG, progesterone; 5α-dione, 
5α-androstanedione; 11KDHT, 11-ketodihydrostestosterone. 
 
 
Keywords: castration, cortisol, sheep, sperm, testosterone  
 
 
1. Introduction 
 
Physical castration of male livestock is used as a management tool to control aggression and 
reproduction (Pinckard et al., 2000), while improving carcass and meat quality (Sales, 2014). 
However, increased consumer awareness about animal welfare has placed pressure on the meat 
industry to reconsider the use of physical castration in livestock. The primary concern 
associated with the various physical castration methods is the pain and stress inflicted on the 
animal, despite the use of pain mitigation (Melches et al., 2007). With physical castration, feed 
efficiency and growth rate are also compromised due to a decrease in circulating concentrations 
of anabolic steroid hormones, of which testosterone is the most well-documented in this regard 
(Sales, 2014).  
Testosterone production in the testis is governed by luteinizing hormone (LH), which 
is under the endocrine control of gonadotropin-releasing hormone (GnRH) released from the 
hypothalamus. Within the Leydig cells of the testes, cholesterol is continuously converted and 
metabolised until it forms dehydroepiandrosterone (DHEA), which is subsequently converted 
to androstenedione (A4), and finally testosterone (T) (Miller & Auchus, 2011). Testosterone, 
through a negative feedback mechanism, inhibits the secretion of LH and follicle stimulating 
hormone (FSH) from the anterior pituitary. The interruption of the negative feedback 
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mechanism of testosterone on LH and FSH levels consequently result in the levels of the latter 
two hormones being elevated after physical castration in lambs (Schanbacher, 1980).  
Immunocastration is made possible by injecting the animal with a vaccine, some of 
which are commercially available such as Improvac®, that typically consists of GnRH 
conjugated to a foreign protein. Generally, after two doses of the Improvac® vaccine, antibody 
production against GnRH is stimulated thus inhibiting the action of GnRH on the pituitary 
gland. In the absence of the stimulatory effect of GnRH, LH and FSH production is prevented, 
interrupting the hypothalamic-pituitary-gonadal axis and thus testosterone production within 
the testes (Claus et al., 2007). Although physical castration eliminates testosterone production 
by the Leydig cells of the testis, various androgen precursors such as DHEA, A4 and 11β-
hydroxyandrostenedione (11OHA4) can be produced by the zona reticularis tissue of the 
adrenal glands (Fig. 1; Xing et al., 2011; Schloms et al., 2012; Morimoto et al., 2013).  
The role of the above-mentioned androgen metabolites and their precursors in the 
various steroid pathways have been studied in humans with prostate cancer, as patients may 
receive androgen deprivation therapy to decrease testosterone production levels. In response, 
the prostate tumour makes use of alternate pathways where adrenal A4 is 5α-reduced to 5α-
dione and subsequently to 5α-dihydrotestosterone (DHT) (Chang et al., 2011). Adrenal A4 may 
also be converted to 11OHA4 (Fig.1), which forms part of the 11OHA4 pathway implicated in 
the development of castration-resistant prostate cancer (Storbeck et al., 2013). In the absence 
of testosterone in castrated animals, androgen precursors may also be converted into active 
androgens using similar pathways.  
Although the influence of immunocastration on production and reproduction 
parameters in swine and cattle is relatively well-documented, as discussed by Needham et al., 
(2017), information regarding the effect of immunocastration in sheep is scarce. The 
immunocastration of rams has been successful in decreasing testosterone secretion using 
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recombinant ovalbumin-GnRH vaccines (Ülker et al., 2003), GnRH-keyhole limpet 
hemocyanin vaccines (Kiyma et al., 2000) and Improvac® (Janett et al., 2003). However, the 
influence of different vaccination intervals, as well as the subsequent pattern of testosterone 
decrease have not been thoroughly investigated. Furthermore, no commercial vaccination 
protocol currently exists for application in rams. Before immunocastration can be 
recommended for use in the sheep industry, it is imperative that aspects such as vaccination 
interval and age at which to administer the vaccine needs to be determined. 
The aim of this study was therefore to determine whether the interval between first and 
second immunocastration vaccination influences the pattern of testosterone suppression in 
rams and production of androgen metabolites involved in alternative steroid metabolism 
pathways. Furthermore, the effects of varying vaccination intervals and suppressed testosterone 
production on testis tissue activity was investigated.  
 
2. Materials and methods 
 
The protocol and procedures for this study were reviewed and approved by the Research Ethics 
Committee: Animal Care and Use, Stellenbosch University (SU-ACUD15-00073). 
 
2.1 Animals, vaccination and blood collection 
The animals used in this trial formed part of a growth study, of which further details can be 
found in Needham et al. (2016). Briefly, forty Dohne Merino ram lambs (35.0 ± 2.18 kg; 5.5 
months of age) were allocated to one of four treatment groups. Three injection intervals were 
investigated, namely two (IC2), three (IC3) or four (IC4) weeks between primary and 
secondary vaccinations (Fig. 2), with the fourth treatment group being the control/intact rams 
(R). All secondary vaccinations were given four weeks prior to slaughter for all 
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immunocastrated treatments. Immunocastration was performed using 2 mL Improvac® (Reg. 
no. G3643, Act 36/1947, Zoetis Animal Health) per dose, injected subcutaneously with a 
SekurusTM injector (SimcroTM, New Zealand), into the wool-free area behind the foreleg, 
alternating first left for the primary injection and then the right side for the secondary injection. 
Each injection site was disinfected using a 70 % ethanol spray prior to vaccine administration.   
Blood samples were collected weekly by means of venepuncture from the jugular vein 
into 6 mL Z Serum Clot Activator Vacuettes® for each immunocastrated treatment group, 
starting from their respective first vaccination as indicated within the sampling schedule (Fig. 
2). Intact controls were sampled for the duration of the trial. During the sixth week of the trial, 
all animals were sampled three times, at intervals of two days (D1, D3 and D5) to ascertain 
how rapidly the effects on androgen production could be observed (Fig. 2). Blood was sampled 
again two weeks later, in the eighth week of the trial.  Blood samples were taken strictly at the 
same time of day, prior to any other measurement on the lambs, attempting to minimise the 
effect of circadian rhythms and handling stress on the serum androgen and cortisol results, 
respectively. It is inevitable that any human interaction will influence cortisol secretion and 
thus blood was not sampled from animals according to an order relating to their treatment 
group, but rather animals were sampled in no particular order from the entire flock of lambs as 
they moved through the handling facility. Blood collection was performed from 9 am on the 
respective sampling days, from late winter (daylength ~ 10 to 11 hours) to early spring 
(daylength ~ 11 to 13 hours) and was completed within approximately one hour after the 
animals entered the handling facilities. Blood samples were centrifuged 45 minutes after 
collection for 15 minutes at 1500 RCF and 4 °C, and the serum samples stored at – 20 ° C until 
later analysis.  
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2.2 Androgenic steroid analysis 
Steroid extraction and analysis was based on the ultra-performance convergence 
chromatography tandem mass spectrometry (UPC2-MS/MS) methodology developed by 
Quanson et al. (2016). Steroids were extracted from the serum samples by adding 50 µL of 
deionized water, containing the internal standards cortisol-9, 11, 12, 12-d4 (15 ng per sample), 
testosterone-1, 2-d2 (1.5 ng per sample) and progesterone-2, 2, 4, 6, 5, 17α, 21, 21, 21-d9 (15 
ng per sample; Cambridge Isotope Laboratories, Andover, USA), to 500 µL of serum.  These 
internal standards were also used to generate standard curves. Subsequently, 1.5 mL of tert-
Methyl Butyl Ether, MTBE, (UHPLC grade, Sigma-Aldrich, Steinheim, Germany) was added 
to each sample for a liquid-liquid extraction at a ratio of 3:1 volume of MTBE to serum and 
vortexed at 1000 RPM for 10 minutes. The serum samples were then frozen at – 80 °C for 60 
minutes after which the non-polar phase was transferred to a clean test tube and evaporated at 
55°C under a constant nitrogen gas stream. The dried steroids were reconstituted in 150 µL of 
50 % methanol (ROMIL, Cambridge, England) and stored at – 20 °C prior to analysis by UPC2 
MS/MS.  
The following steroid metabolites were assayed: testosterone (T), cortisol (CORT), 
progesterone (PROG), androstenedione (A4), 5α-androstanedione (5α-dione), 5α-
dihydrotestosterone (DHT) and 11-ketodihydrostestosterone (11KDHT). The metabolites were 
quantified using an Acquity UPC2 system fitted with an Acquity UPC2 BEH 2-EP (3 mm x 100 
mm; 1.7 µm) column (Waters Corporation, USA) under conditions specified by Quanson et al. 
(2016). 
 
2.3 Testes collection and measurements 
All sheep were slaughtered according to standard commercial practices, as detailed by 
Needham et al. (2016). The testes were collected on the slaughter line and transported on ice 
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to the laboratory for further processing. Upon arrival, the testes were removed from the scrotum 
and trimmed free of the epididymis and connective tissue before both testes were weighed as a 
pair (RADWAG PS750/C/2 scale, Wagi Elektroniczne, Poland; accurate to 0.001g). Each testis 
was then cross-sectioned perpendicular to the longitudinal axis to immediately measure the cut 
surface CIE Lab colour using a Color-guide 45°/0° colourimeter (BYK-Gardner GmbH, 
Gerestried, Germany), in accordance with Lealiifano et al. (2011). The CIE colour space 
system describes colour visible to the human eye using a mathematical three-dimensional 
model. The value “L” describes “lightness” of the surface being measured (0 indicates black, 
while 100 indicates diffuse white), whereas “a” and “b” are assigned for the colour co-ordinates 
green (negative values) to red (positive values), and blue (negative values) to yellow (positive 
values), respectively.  
Tissue samples (approximately 1 cm x 1 cm) were collected from the mid-section of 
the testis and placed in buffered formalin to be preserved for preparation of histology slides 
(Bai et al., 2017). These tissue samples were washed with water and dehydrated in a graded 
alcohol series before embedding in paraffin. Tissue samples were then sliced into 5 µm thick 
sections, placed onto microscope slides and stained with haematoxylin and eosin. Seminiferous 
tubule circumference and epithelium thickness were evaluated using an Olympus IX70 
microscope (Olympus Corporation Tokyo, Japan) at 40X magnification and Olympus Image 
Analysis Software (Olympus Corporation Tokyo, Japan), measuring 100 seminiferous tubules 
per ram. After the epididymides were trimmed from the testes, they were placed in petri dishes 
containing Ham’s F10 Nutrient Mixture (Merck, Germany) at room temperature to prevent 
dehydration. Sperm was harvested from epidydimides; however, only five immunocastrated 
lambs had sperm present and thus further morphological analyses were not included.  
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2.4 Statistical analysis 
Statistical analysis was performed using STATISTICA 13 (StatSoft Inc.). Normality of 
residuals was ensured, and homogeneity was tested using Levene’s test. The Variance 
Estimation, Precision and Comparison (VEPAC) procedure was used to assess the androgenic 
steroid concentrations over the trial period using a mixed model repeated measure analysis of 
variance (ANOVA). Fixed effects included treatment and week, with animals being the random 
variable. One-way analysis of variance (ANOVA) were used to evaluate the data for the testis 
parameters. Fishers LSD was the chosen post hoc test to compare treatment means. In the case 
where the assumption of homogeneity was not met (testes weights), Games Howel post hoc 
tests were performed. Differences are reported at P ≤ 0.05. 
 
3. Results 
 
3.1 Androgenic steroid concentrations 
Results for serum testosterone (T) concentrations are presented in Figures 3 and 4, cortisol 
(CORT) concentrations in Figures 5 and 6, and androstenedione (A4) concentrations are 
presented in Figures 7 and 8. Concentrations for 5α-dihydrotestosterone, progesterone, 5α-
androstanedione and 11-ketodihydrostestosterone were non-detectable over the trial period, 
and thus deemed negligible.  
The pre-treatment concentrations are represented by the data points on Weeks 1, 2 and 
3 for ICS4, ICS3 and ICS2, respectively, and do not differ from each other for T, CORT and 
A4 (P > 0.05). The interaction effect of “treatment” and “week” was significant for serum T (P 
= 0.004) and A4 (P = 0.014) concentrations, and thus the significant letters within Figures 3, 
4, 7 and 8 represent differences between treatment means over the entire period specified within 
the figure. Serum T concentration decreased over the three weeks after the primary vaccination 
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for IC4, between Week 1 and Week 4 (P = 0.03), with no significant change in T detected again 
within IC4 lambs until Week 6 (Fig. 3). Testosterone concentrations for IC4 lambs were 
significantly lower than R rams at Week 3 (P = 0.03), Week 5 (P < 0.001), Week 6 (P = 0.01) 
and Week 8 (P = 0.02). A decrease in T was experienced within the first week after the primary 
vaccination for both IC3 (P = 0.04) and IC2 lambs (P < 0.001), and they did not experience a 
significant change in concentration for the rest of the trial. The T concentrations were lower (P 
≤ 0.001) during Weeks 5, 6 and 8 for IC3 and IC2 lambs than R rams. Although no significant 
changes in T occurred within the immunocastrated lambs during the intensive sampling period 
of Week 6 (Fig. 4), T concentrations were significantly lower (P ≤ 0.05) on D1, 3 and 5 for all 
immunocastrated lambs compared to R rams.  The intact rams experienced a significant 
increase in T concentrations from Week 4 to 5 (P < 0.001), followed by a decline in T from 
Week 5 to 6 (P = 0.004; Fig. 3), indicating variable secretion. For the last blood sampling point 
(Week 8), no differences were detected for T between IC4, IC3 and IC2 lambs but all 
immunocastrated lambs had lower T concentrations than R rams in Week 8 (P = 0.002).  
When the serum cortisol concentrations are compared between treatments (Fig. 5), no 
differences were found between or within treatment means over the duration of the study and 
during three-day intensive sampling period within Week 6 (Fig. 6). Similar to T, serum A4 
concentration decreased in IC4 lambs over the three weeks after primary vaccination (Fig. 7), 
between Week 1 and 4 from 0.25 ± 0.055 ng/mL to undetectable levels (P < 0.001). For IC3 
lambs, A4 decreased over the two weeks after primary vaccination between Week 2 and 4 (P 
= 0.007), and IC2 lambs experienced a decrease in A4 within one week after primary 
vaccination (P < 0.001). Between Weeks 4 and 5, IC4 lambs showed a sharp increase in A4 
from undetectable levels to 0.17 ± 0.055 ng/mL (P < 0.001) such that they had greater A4 
concentrations compared to IC3 (P = 0.006) and IC2 (P = 0.001) but did not differ to that of R 
rams at this point. Differences between immunocastrated lambs and R rams were seen during 
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Week 3 where IC4 lambs had lower A4 concentrations than R (P = 0.01), and during Week 6 
where IC3 and IC2 lambs had lower A4 than R rams (P = 0.03). During the intensive blood 
sampling, all three immunocastrated treatment groups reached non-detectible A4 serum 
concentrations by D3, while R lambs had A4 concentrations of 0.10 ± 0.039, 0.07 ± 0.044 and 
0.03 ± 0.033 ng/mL on D1, D3 and D5 respectively (Fig. 8).  
 
3.2 Testis parameters 
Results for paired testes weight, testis tissue colour, seminiferous tubule circumference and 
seminiferous epithelium thickness are presented in Table 1.  
Immunocastration resulted in a decrease in trimmed testes weight, regardless of 
vaccination treatment (P < 0.001; Table 1 & Fig. 9). Treatment influenced the cut surface CIE 
colour values, with the IC3 testes having higher a* colour values than IC2 testes (P = 0.02; 
Table 1). All immunocastration treatments increased b* values of the cut testes tissue surface 
(P < 0.001). In some immunocastrated lamb testes, adhesions had formed between the 
epididymis and the tunica albuginea, which complicated dissecting the epididymis free from 
each testis (Fig. 10). Darkening of epidydimal tissue was observed in one if the IC2 lambs, 
indicating a possible thrombosis (Fig. 10).  
Histological evaluation of the testes indicated that regardless of vaccination interval, 
immunocastration interrupted spermatogenesis, as evident by the thinner seminiferous 
epithelium, and smaller seminiferous tubule circumferences (P < 0.001) compared to non-
vaccinated controls (Table 1; Fig. 11). Not only did the non-vaccinated rams have thicker 
seminiferous tubule epithelium compared to the immunocastrated lambs (P < 0.001), 
differences also existed between immunocastrated treatments (Table 1). The lambs 
immunocastrated with a four-week interval had thicker seminiferous tubule epithelium than 
both those vaccinated with a three and two-week interval (P = 0.03 and P = 0.02 respectively). 
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5. Discussion  
 
In this study, the effects of varying intervals between primary and secondary (booster) 
vaccinations for immunocastrating rams were evaluated for serum cortisol and androgen 
concentrations, testes size and seminiferous tubule size.  
The extra-label use of Improvac® in mares reported reactions at the injection site in 89 
% of the mares, which could result in pain and stress (Imboden et al., 2006). Thus, serum 
cortisol concentrations were determined throughout this study to ascertain whether reactions at 
the injection site, or a particular vaccination interval, elicits a stress response within 
immunocastrates due to pain or inflammation. However, no significant differences were 
reported for cortisol concentrations and thus the reaction sites for the respective treatments 
described by Needham et al. (2016) did not appear to influence the stress response of the 
relevant animals. All vaccination intervals used for immunocastration in this study were 
successful in suppressing serum testosterone concentrations to negligible concentrations after 
the second vaccination (Fig. 3). However, all immunocastration treatments experienced a 
decrease in testosterone between the primary and secondary vaccination. Typically, two doses 
of Improvac® are required to significantly influence the testosterone secretion of swine (Claus 
et al., 2007), but in rams one dose seemed to significantly influence testosterone secretion. 
Although the efficacy of immunocastration on ultimate testosterone concentrations was the 
same for all vaccination intervals, the three and two-week vaccination intervals resulted in a 
rapid and sustained decrease in testosterone concentrations from primary vaccination 
throughout the trial. Thus, the shorter inter-vaccination periods may be preferred in terms of 
rapid testosterone and sustained reduction. Both testosterone and cortisol secretion are under 
the influence of circadian rhythms as well as various environmental factors, and despite 
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controlling the time of day for blood withdrawal, interpretation of the results of one blood 
withdrawal per week is somewhat limited. Although other immunocastration studies in lambs 
have made use of a single blood sampling per day/week (Kiyma et al., 2000; Ülker et al., 2005; 
Ülker et al., 2009; Gökdal et al., 2010), multiple blood withdrawals should be performed per 
day to improve the accuracy of serum testosterone and cortisol concentration determination in 
an attempt to limit the variability in future studies.  
Declining A4 concentrations after the second vaccination until the end of the trial (Fig. 
7) may indicate the conversion of this androgen metabolite to further androgen precursors (Fig. 
1). Conversion of these precursors takes place in peripheral tissues and therefore serum 
concentrations may not reflect this change per se. Thus, perhaps extraction from androgenic 
tissue itself may provide a better representation of the influence of immunocastration treatment 
on these androgen pathways.  
In response to decreased testosterone secretion, immunocastration reduced testes 
activity and size, interrupting spermatogenesis. Immunocastration, with a range of 
experimental vaccines, has been shown to successfully suppress testes development in rams 
over various ages (Kiyma et al., 2000; D’Occhio et al., 2001; Janett et al., 2003). Evaluation of 
the testis tissue from all immunocastrated lambs within this study, regardless of vaccination 
interval, indicated atrophy of the seminiferous tubules. The slight increase in testosterone 
concentration after second vaccination of IC4 lambs may have influenced the degree to which 
their seminiferous tubule epithelium activity was affected; although, the difference in thickness 
between seminiferous tubule epithelium thickness of immunocastrated lambs within the 
present study was only ~ 3 µm. The presence of sperm in the epididymides of the five 
immunocastrated rams may therefore be attributed to incomplete clearance as a minimum 
amount of time is required for the epididymides to be free of sperm. Sperm take approximately 
40 to 60 days (average 56 days) to form and be transported through the epididymis for 
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ejaculation in rams (Foote, 1978; Gimenez & Rodning, 2007), undergoing maturation within 
the epididymis between seven to 14 days (Dacheux & Dacheux, 2014). The difference in the 
respective testis cut surface colour values may also be an indication of different levels of 
spermatogenetic activity occurring in the testes between treatment groups (Lealiifano et al., 
2011). Immunocastrated rams had “redder” (a*) and “yellower” (b*) testis surface colour 
which is possibly an indication of decreased sperm concentration within the testis. A higher 
sperm concentration in intact males could possibly contribute to the less red appearance of the 
testes when cut open. Thus, lambs receiving their primary vaccination earliest may experience 
inhibited testes functioning sooner compared to lambs vaccinated at a later stage. Semen 
quality, sperm concentration and sperm viability therefore need to be investigated over time 
ante-mortem.  Establishing when exactly the decrease in testosterone secretion begins to 
interrupt spermatogenesis may indicate at what time point immunocastrated lambs are 
considered infertile and can safely be placed in mixed sex flocks. Furthermore, the intervals 
between secondary vaccination and slaughter needs to be investigated to ensure that 
testosterone secretion remains suppressed when the period between second vaccination and 
slaughter is extended. This statement is motivated by the desire for a flexible vaccination 
schedule that can be used within the wide range of lamb production systems, involving multiple 
breeds fed various diets and thus requiring different fattening periods. 
 
6. Conclusion 
 
Improvac® can successfully be used in ram lambs to decrease testosterone production and testis 
functioning using a flexible vaccination interval ranging from four, three or two weeks between 
the primary and secondary vaccination. However, due to the rapid and sustained decrease in 
testosterone concentrations within lambs immunocastrated using either three or two weeks 
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between vaccinations, a shorter vaccination interval may be preferred. To further substantiate 
this conclusion, the influence of lower testosterone concentrations in immunocastrated lambs 
on sexual and aggressive behaviour needs to be quantified.  
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Fig 1. Androgen biosynthesis in the Leydig cells of the testes (top) and the zona reticularis of 
the adrenal glands (bottom) (adapted from Quanson, 2015, Miller and Auchus, 2011, and Xing 
et al., 2011) 
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Fig 2. The vaccination protocol of immunocastrated (IC) and intact rams (control/R) during a 
nine-week growth period. Vaccination administration intervals were either two (IC2), three 
(IC3) or four (IC4) weeks, with the second vaccination given to all immunocastrates four weeks 
prior to slaughter (start of week nine), as indicated by the arrows. Weekly blood collection is 
indicated per treatment group, with an intensive blood sampling performed in all groups during 
Week 6. 
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Fig 3. The average (±SE) serum testosterone concentration (ng/mL) measured in 
immunocastrated (IC) and intact rams (R) during a nine-week growth period. Primary 
vaccinations (solid arrows) were administered to the immunocastrated groups at Week 1 (IC4), 
Week 2 (IC3) or Week 3 (IC2). The second vaccination was administered to all 
immunocastrates at Week 5 (dashed arrow). The interaction for “treatment” and “week” is 
significant (P = 0.004) and thus letters indicate differences between treatment means over the 
eight-week study period (P ≤ 0.05). 
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Fig 4. The average (± SE) serum testosterone concentrations (ng/mL) of immunocastrated (IC) 
and intact rams (R) for the intensive blood sampling period during Week 6, following the 
secondary vaccination. Vaccinations were given at an interval of four (IC4), three (IC3) or two 
(IC2) weeks. The interaction for “treatment” and “day” is significant and thus letters indicate 
differences between treatment means over the three-day study period (P ≤ 0.05). 
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Fig 5. The average (±SE) serum cortisol concentrations (ng/mL) measured in immunocastrated 
(IC) and intact rams (R) during a nine-week growth period. Primary and secondary 
vaccinations are indicated by the solid arrows. The secondary vaccination was administered at 
Week 5 (dashed arrow). Vaccination intervals include four (IC4), three (IC3) and two (IC2) 
weeks. No interaction or main effect differences were reported (P > 0.05) and thus letters 
indicating significance have been omitted.  
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Fig 6. The average (± SE) serum cortisol concentrations (ng/mL) measured in immunocastrated 
(IC) and intact rams (R) during Week 6, following the second vaccination. Immunocastrates 
were vaccinated at intervals of either four (IC4), three (IC3) or two (IC2) weeks. No interaction 
or main effect differences were reported (P > 0.05) and thus letters indicating significance have 
been omitted.   
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Fig 7. The average (±SE) serum androstenedione concentrations (ng/mL) measured in 
immunocastrated (IC) and intact rams (R). Solid arrows indicate the primary vaccinations for 
respective treatments and the dashed arrow indicates the secondary vaccination administration 
for all immunocastrated groups. Vaccination intervals were either four (IC4), three (IC3) or 
two (IC2) weeks The interaction for “treatment” and “week” is significant (P = 0.014) and thus 
letters indicate differences between treatment means over the eight-week study period (P ≤ 
0.05). 
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Fig. 8 The average (± SE) serum androstendione concentrations (ng/mL) measured in 
immunocastrated (IC) and intact rams (R) during Week 6, following the second vaccination. 
Immunocastrates were vaccinated at intervals of either four (IC4), three (IC3) or two (IC2) 
weeks. The interaction for “treatment” and “day” is significant and thus letters indicate 
differences between treatment means over the three-day study period (P ≤ 0.05). 
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Fig 9. The testes (with epididymides still attached) of an intact control ram (left) compared to 
a ram immunocastrated using Improvac® (right) indicating differences in size.  
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Fig 10. Thickening and attachment of the tunica albuginea observed in immunocastrated lambs 
(left) and possible thrombosis of the epididymis was observed in one immunocastrated lamb 
(right), following a two-week interval between vaccinations. 
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Fig 11. Micrographs of cross-sections of testis tissue from immunocastrated (IC) and intact (R) 
rams. Slides were stained with haematoxylin and eosin and analysed at a magnification of 40X. 
Immunocastration resulted in atrophy of the seminiferous tubules (arrow), decreased 
epithelium thickness (line) and resultant increased lumen space (asterisk).  
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
32 
 
 
Table 1. The effect of vaccination interval on the testes weight, CIE colour values and 
seminiferous tubule parameters (LSMean ± SE) of Dohne Merino ram lambs. 
  
Treatment group 
R IC4 IC3 IC2 
Trimmed testes weight, g 
258.5a ± 
19.58 
80.0b ± 8.15 76.7b ± 4.71 90.1b ± 9.44 
Seminiferous tubule     
Circumference, µm 
791.5a ± 
34.84 
534.7b ± 
17.23 
527.3b ± 
18.89 
547.2b ± 
17.59 
Epithelium thickness, 
µm 
52.5a ± 1.04 20.9b ± 1.08 17.5c ± 1.00 17.2c ± 1.07 
CIE colour values      
L* 66.2 ± 0.88 67.3 ± 0,74 67.2 ± 0,64 68.7 ± 0,52 
a*    0.7c ± 0.16     3.8ab ± 0.25     4.1a ± 0.35     3.0b ± 0.44 
b*     9.7b ± 0.49   13.3a ± 0.46 14.1a ± 0.46 13.8a ± 0.46 
a,b LSMeans within rows with different superscripts are significantly different (P ≤ 0.05)  
R = intact control rams 
IC4 = immunocastrates with a 4-week vaccination interval and vaccinated at 1 & 5 weeks 
IC3 = immunocastrates with a 3-week vaccination interval and vaccinated at 2 & 5 weeks 
IC2 = immunocastrates with a 2-week vaccination interval and vaccinated at 3 & 5 weeks 
SE = standard error  
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